The results will help researchers design potential treatments for people affected by a variety of vision-robbing conditions.

The Foundation’s national trustees leadership group expands with six new supporters appointed to key roles.

A new study refuels the debate over whether use of the drug increases the risk of advanced age-related macular degeneration.

Gene therapies, stem cell treatments and vision-preserving plant extracts were among the subjects covered by participants in the Foundation’s annual TRAP meeting in Las Vegas.